OncLive SOSS

ELCC Updates in Immunotherapy and Beyond for Non–Small Cell Lung Cancer - Episode 5

Data Updates on Single-Agent Immunotherapy in Advanced NSCLC

May 9, 2023

Jarushka Naidoo, MD, M.B.B.Ch., Solange Peters, MD, PhD, Marina Chiara Garassino, MD

Experts explain recent data updates on single-agent immunotherapy treatment for patient with advanced NSCLC.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Overview of PD-L1 Testing in Advanced NSCLC

EP. 2: Subgrouping Patients with Advanced NSCLC for Tailored Treatment

EP. 3: CTLA-4 Targeted Regimens in Advanced NSCLC

EP. 4: Updates in Gender-Based Treatment for Patients with Advanced NSCLC

EP. 5: Data Updates on Single-Agent Immunotherapy in Advanced NSCLC

EP. 6: Updates from ELCC: Efficacy of Frontline Nivolumab + Ipilimumab in Metastatic Non-Squamous NSCLC

EP. 7: Updates from ELCC: 5-Year Update on Pembrolizumab vs Chemotherapy in Advanced NSCLC

EP. 8: Updates from ELCC: Advanced NSCLC and the EMPOWER-Lung1 Trial

EP. 9: Combination Chemotherapy and Immunotherapy for Advanced NSCLC

EP. 10: The Evolution of Chemoimmunotherapy in Advanced NSCLC

Sponsored in part by Regeneron. Content independently created by OncLive.

x